Torrent Pharmaceuticals shines on planning to raise up to Rs 5,000 crore
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Torrent Pharmaceuticals is currently trading at Rs. 1797.70, up by 82.90 points or 4.83% from its previous closing of Rs. 1714.80 on the BSE.
The scrip opened at Rs. 1754.90 and has touched a high and low of Rs. 1851.15 and Rs. 1744.50 respectively. So far 38530 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1,851.15 on 31-May-2023 and a 52 week low of Rs. 1343.88 on 09-Jun-2022.
Last one week high and low of the scrip stood at Rs. 1851.15 and Rs. 1684.50 respectively. The current market cap of the company is Rs. 61392.31 crore.
The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 21.04% and 7.71% respectively.
Torrent Pharmaceuticals is planning to raise up to Rs 5,000 crore through the issuance of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. The Board of Directors of the company in its meeting held on May 30, 2023 has recommended to the members to obtain enabling approval for the same.
Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
